Dr. David Perlmutter, World-Renowned Neurologist and GlutathioneExpert, Featured With Dr. Oz on Oprah and Friends, Joins Scientific Advisory Board of LifeVantage Corporation
* Reuters is not responsible for the content in this press release.
Dr. Perlmutter, Respected Neurologist, Glutathione and Antioxidant Expert Was Featured April 3, 2009 on Oprah and Friends With Dr. Oz to Discuss New Findings Affecting Parkinson`s Disease SAN DIEGO--(Business Wire)-- David Perlmutter, MD, FACN, ABIHM, internationally recognized for his expertise in the field of neurology and recently featured with Dr. Oz on Oprah and Friends, has joined the Scientific Advisory Board of LifeVantage Corporation (OTCBB: LFVN).The Company`s products include Protandim® - a dietary supplement clinically shown to induce the body`s own antioxidant defenses. Currently, Dr. Perlmutter is involved in pioneering work in the use of glutathione in fighting diseases such as Parkinson`s disease and Alzheimer`s. Dr. Perlmutter appeared on Oprah and Friends on April 3, 2009 with Dr. Oz to discuss new findings affecting Parkinson`s disease (www.oprah.com/oradio). Protandim® was proven to raise glutathione levels up to 300 percent, in a peer-reviewed study published in November 2008 in theFree Radical Biology and Medicine Journal. Dr. Perlmutter commented, "The health benefits of increased glutathione are numerous, because of its antioxidant and potential anti-aging activity factors. Protandim`s® effects on glutathione enhancement are tremendous and as a neurologist, I am keenly interested in the impact of Protandim® on brain disorders as well as a variety of medical conditions and diseases. Working with LifeVantage provides me the ability to discuss the eloquence of the science supporting this product and its profound importance in human health." David Brown, LifeVantage President and CEO said, "We are very pleased to welcome Dr. Perlmutter on board with the LifeVantage team. He is known worldwide as an expert in his field, evidenced by his recent appearance with Dr. Oz on the Oprah and Friends show - he has the ability to disseminate the Protandim® message to potentially millions of consumers." About Dr. Perlmutter David Perlmutter, MD, FACN, ABIHM is a Board-Certified Neurologist and Fellow of the American College of Nutrition who received his M.D. degree from the University of Miami School of Medicine where he was awarded the Leonard G. Rowntree Research Award. After completing residency training in Neurology, also at the University of Miami, Dr. Perlmutter entered private practice in Naples, Florida. Neurologist Dr. Perlmutter has contributed extensively to the world of medical literature with publications appearing in such journals as The Journal of Neurosurgery, The Southern Medical Journal, Journal of Applied Nutrition, and Archives of Neurology. He is the author of the bestselling book, The Better Brain Book and Raise a Smarter Child By Kindergarten and is recognized internationally as a leader in the field of nutritional influences in neurological disorders. He has lectured at symposia sponsored by such respected institutions as the University of Arizona, the University of Miami, Columbia University, and Harvard University. Neurologist Dr. Perlmutterhas been interviewed on many nationally syndicated radio and television programs including 20/20, Larry King Live, CNN, Fox News, Fox and Friends, The Today Show, Oprah, Oprah and Friends, Oprah Radio with Dr. Oz, and The CBS Early Show. He was awarded the 2002 Linus Pauling Award for his pioneering work in innovative approaches to neurological disorders and is the recipient of the 2006 National Nutritional Foods Association Clinician of the Year Award. For more, visit www.LifeVantage.com/Glutathione. About Protandim® Protandim® is a groundbreaking, clinically proven supplement that provides a substantial benefit to help with the challenge of healthy aging. This patented antioxidant therapy is more powerful than conventional foods such as red wine, oranges, blueberries or other popular antioxidant supplements. Protandim® works by increasing the body`s natural antioxidant protection at the cellular level, triggering cells to produce naturally occurring protective antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione synthase. A peer-reviewed human study showed that after Protandim® was taken for 30 consecutive days, the accumulation of lipid peroxidation products (a biochemical marker of aging) was decreased by an average of 40%. The study also reported that this important marker of aging was decreased after taking Protandim® to the level of a typical 20 year old. Protandim® is currently the subject of over 20 scientific studies at leading universities and research institutes. For more information, please visitwww.LifeVantage.comor contact Jan Strode (619) 890-4040 or Jean Golden (612) 385-2324. About LifeVantage Corporation LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science based, natural products company, dedicated to helping people reach their health and wellness goals through science-based solutions to oxidative stress. Founded in 2003 and based in San Diego, CA, LifeVantage develops nutraceutical products, including Protandim®, that leverage the company's expertise and that are intended to deliver significant health benefits to consumers. For more information, visit www.LifeVantage.com or contact Jan Strode (619) 890-4040 or Jean Golden (612) 385-2324. This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.The Company uses the words "anticipate," "believe," "could," "should," "estimate," "expect," "intend," "may," "predict," "project," "plan," "target" and similar terms and phrases, including references to assumptions, to identify forward-looking statements. These forward-looking statements are based on the Company`s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein.These risks and uncertainties include, among others, the risk that government regulators and regulations could adversely affect our business; future laws or regulations may hinder or prohibit the production or sale of our existing product and any future products; unfavorable publicity could materially hurt our business; and the Company`s ability to protect our intellectual property rights and the value of our product.These and other risk factors are discussed in greater detail in the Company`s Annual Report on Form 10-KSB under the caption "Risk Factors", and in other documents filed the Company from time to time with the Securities and Exchange Commission.The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document.All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Note to Editors: Contact Jan Strode at 619-890-4040 or Jean Golden at 612-385-2324 for interviews, photography, and other requests. For LifeVantage Corporation Jan Strode, 619-890-4040 Jean Golden, 612-385-2324 Copyright Business Wire 2009
- Housing, jobs data weaken, but overall economic picture still upbeat
- Last-minute Obamacare exemption for those with canceled plans
- UPDATE 6-Target cyber breach hits 40 mln payment cards at holiday peak
- Target cyber breach hits 40 million payment cards at holiday peak |
- New York Mayor-elect's reputation for lateness parodied on Twitter